Type 2 diabetes
Clinical research activity is centered on type 2 diabetes mellitus, with attention to metabolic control and its impact on long-term organ health.
- Glycaemic disease management
- Metabolic complications
- Cardiometabolic risk
The sponsor’s funded work in this area reflects interest in diabetes-related outcomes that extend beyond glucose regulation, including broader systemic effects.
Cardiovascular effects of diabetes therapies
Research activity includes the relationship between SGLT-2 inhibitors and cardiovascular health in people with type 2 diabetes, with emphasis on treatment-associated effects on the heart and circulation.
- Cardiovascular protection
- Heart function
- Circulatory outcomes
This area aligns with interest in how diabetes treatments influence cardiovascular status alongside metabolic disease.
Autonomic nervous system and cardiac regulation
The sponsor is involved in research on autonomic innervation and its role in mediating treatment effects, with specific focus on cardiac autonomic neuropathy in type 2 diabetes.
- Autonomic dysfunction
- Cardiac autonomic neuropathy
- Neurocardiac regulation
These interests place emphasis on the interaction between the nervous system and cardiovascular responses in diabetes.
Diabetes-related neuropathic complications
Research extends to the progression of cardiovascular autonomic neuropathy, highlighting complications that affect cardiovascular control and disease burden in diabetes.
- Neuropathic progression
- Diabetes complications
- Autonomic cardiovascular impairment
The clinical focus is on complications that link metabolic disease with impaired autonomic and cardiac function.
